Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -4024.93% is 177% below its 5-year average of -1450.48%, around the middle of its 5-year range (-12907.69%–-6.80%).
2.59% below its 12-month average of -3923.50%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -6.80%.
OPERATING MARGIN
-4024.93%
OPERATING MARGIN AVG TTM
-3923.50%
OPERATING MARGIN AVG 3Y
-2026.22%
OPERATING MARGIN AVG 5Y
-1450.48%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.59%
CURRENT VS 3Y AVG
-98.64%
CURRENT VS 5Y AVG
-177.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 495 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aligos Therapeutics, Inc.
Market Cap
$33.42M
Operating Margin
-4024.93%
TTM Avg
-3923.50%
3Y Avg
-2026.22%
5Y Avg
-1450.48%
Market Cap
$33.52M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1396.17%
Market Cap
$32.32M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-689.10%
5Y Avg
-7222.03%
Market Cap
$32.31M
Operating Margin
-36.42%
TTM Avg
-233.99%
3Y Avg
-181.69%
5Y Avg
-124.85%
Market Cap
$31.36M
Operating Margin
-113.31%
TTM Avg
-35.98%
3Y Avg
1.15%
5Y Avg
17.00%
Market Cap
$35.89M
Operating Margin
-6.58%
TTM Avg
-2.44%
3Y Avg
-1.06%
5Y Avg
0.55%
Market Cap
$30.92M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.42M | -4024.93% | -3923.50% | -2026.22% | -1450.48% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | 0.00% | 0.00% | 0.00% | -1396.17% |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | 0.00% | 0.00% | -689.10% | -7222.03% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | -36.42% | -233.99% | -181.69% | -124.85% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -113.31% | -35.98% | 1.15% | 17.00% |
| Accuray Incorporated (ARAY)vs › | $35.89M | -6.58% | -2.44% | -1.06% | 0.55% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| DocGo Inc. (DCGO)vs › | $36.05M | -27.67% | -11.51% | -3.91% | -4.42% |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00% | 0.00% | 0.00% | 0.00% |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
57.5%
Operating Margin
-4024.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -6.80% |
| 2026-03-31 | -951.55% |
| 2025-12-31 | -12907.69% |
| 2025-09-30 | -3827.40% |
| 2025-06-30 | -1924.04% |
| 2025-03-31 | -6187.46% |
| 2024-12-31 | -3269.16% |
| 2024-09-30 | -1586.37% |
| 2024-06-30 | -2489.54% |
| 2024-03-31 | -2235.90% |
| 2023-12-31 | -969.68% |
| 2023-09-30 | -588.79% |
| 2023-06-30 | -277.97% |
| 2023-03-31 | -878.37% |
| 2022-12-31 | -641.28% |
| 2022-09-30 | -461.47% |
| 2022-06-30 | -552.21% |
| 2022-03-31 | -1383.00% |
| 2021-12-31 | -10340.05% |
| 2021-09-30 | -2151.46% |
| 2021-06-30 | -1913.59% |
| 2021-03-31 | -3048.35% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
